June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

FTSE slides after BOE meeting as pound pops higher

Published 08/02/2018, 17:09
© Reuters. A worker shelters from the rain as he passes the London Stock Exchange in London
UK100
-
BATS
-
BARC
-
LLOY
-
NWG
-
GILD
-
AZN
-
RKT
-
WPP
-
GSK
-
BHPB
-
RRS
-
ANTO
-
ULVR
-
CPG
-
PUBP
-
HG
-
TALK
-
SOPH
-

By Danilo Masoni and Kit Rees

MILAN/LONDON (Reuters) - The UK's top share index fell on Thursday after the Bank of England raised the prospect of higher interest rates, sending the pound higher which weighed on big British overseas earners.

The FTSE (FTSE) was closed 1.5 percent lower at 7,170.69 points. The index is down 6.7 percent in the year to date, making it the worst performer among top European bourses.

The Bank of England said that interest rates probably need to rise sooner and by a bit more than it thought only three months ago, which boosted sterling.

The rise in the currency weighed on the FTSE's predominantly dollar-earning firms, with shares in heavyweight consumer staples British American Tobacco (L:BATS), Reckitt Benckiser (L:RB) and Unilever (L:ULVR) dropping 1.8 percent to 3.2 percent.

"We are growing cautious on those companies which rely heavily on overseas earnings, as rising interest rates could cause the pound to strengthen further from here," Andrew Morgan, portfolio manager of Alpha:r² at Walker Crips, said.

"We continue to be relatively defensively positioned in equities, despite the recent dip, and are looking at certain sectors - such as Financials - which tend to benefit from a rising interest rate environment," Morgan added.

On the day shares in banking stocks RBS (L:RBS), Barclays (L:BARC) and Lloyds (L:LLOY) were among the dozen or so stocks in positive territory, up 0.4 percent to 1 percent.

GlaxoSmithKline (L:GSK) was another riser, up 1.4 percent after U.S. regulators delayed approval of a generic copy from Novartis of its blockbuster Advair lung drug and after the group took legal action against Gilead Sciences (O:GILD) over a new HIV drug.

The news helped build confidence after an upbeat results presentation by GlaxoSmithKline on Wednesday. Competitive threats to its respiratory and HIV businesses are seen as key risks for the company's stock.

AstraZeneca (L:AZN) rose 1.2 percent, boosted by a price target upgrade from Berenberg.

WPP (L:WPP) rose 3.1 percent following a reassuring update from French peer Publicis (PA:PUBP), while Compass (L:CPG), the world's biggest catering firm, jumped more than 5 percent after it raised its expectations for revenue growth.

Their gains however were more than offset by broad-based weakness as markets remained nervous following a sell-off earlier this week triggered by a spike in global yields and volatility.

Miners, along with energy stocks, were a big weight on the FTSE, with the two commodities-related sectors collectively wiping around 40 points off the index, as prices of copper and other metals fell and oil retreated.

Precious metals miner Randgold (L:RRS) fell 2.4 percent after HSBC raised its rating on the stock but trimmed its price target. Antofagasta (L:ANTO) and BHP Billiton (L:BLT) were also both down around 2.5 percent.

Among midcaps, Sophos (L:SOPH) fell 17.5 percent after the cloud services provider reported slower growth in the amount it bills its customers, while TalkTalk (L:TALK) slumped after flagging a dividend cut and a cash call.

© Reuters. A worker shelters from the rain as he passes the London Stock Exchange in London

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.